Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study.

Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study. Thromb Haemost. 2018 Aug; 118(8):1439-1449.

View in: PubMed

subject areas

Aged
Anticoagulants
Clinical Decision-Making
Dalteparin
Factor Xa Inhibitors
Female
Hemorrhage
Humans
Male
Middle Aged
Neoplasms
Patient Selection
Pyridines
Recurrence
Risk Assessment
Risk Factors
Severity of Illness Index
Thiazoles
Time Factors
Treatment Outcome
Venous Thromboembolism

authors with profiles

Gary E Raskob